# HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma

> **NCT04353375** · PHASE2,PHASE3 · RECRUITING · sponsor: **Hutchmed** · enrollment: 235 (estimated)

## Conditions studied

- Advanced Intrahepatic Cholangiocarcinoma
- Solid Tumor, Adult

## Interventions

- **DRUG:** HMPL-453

## Key facts

- **NCT ID:** NCT04353375
- **Lead sponsor:** Hutchmed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-09-03
- **Primary completion:** 2028-06-30
- **Final completion:** 2030-02-28
- **Target enrollment:** 235 (ESTIMATED)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04353375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04353375, "HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04353375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*